Full-Time

Manager – Sales Success

Posted on 6/3/2025

Zeiss

Zeiss

1,001-5,000 employees

Supplies lithography optics for semiconductor manufacturing

Compensation Overview

$84.4k - $105.5k/yr

+ Performance Bonus + Sales Commissions

Company Does Not Provide H1B Sponsorship

Dublin, CA, USA

In Person

Category
Sales & Account Management
Required Skills
Sales
SAP Products
Oracle
Data Analysis
Requirements
  • Bachelor’s Degree or equivalent experience required, with emphasis in Sales, Order Administration, or Call Center operations and leadership.
  • Minimum of eight years of experience managing a large, customer facing support organization with increasing levels of responsibility.
  • Eight to ten plus years of experience in a management position, preferably in a Sales, Order Administration or Call Center environment.
  • Experience with ERP applications, such as SAP, Oracle and CRM modules.
  • Ability to understand, interact and influence all levels of the organization.
  • Must have excellent analytical and communications skills, oral and written.
Responsibilities
  • Leads the Administrative Teams that support operational functions and drive quality processes and compliance throughout the customer journey including Sales Order Support, Order Admin, and back-office areas.
  • Implement, manage and evaluate operation processes and procedures throughout the Sales Success Operations teams that will be created and defined to help improve customer satisfaction when doing business with Carl Zeiss Meditec.
  • Creation and implementation of call quality and order processing standards and expectations.
  • Oversee the workforce resource planning and management to ensure the corporate strategic plans and objectives are achieved throughout Sales Success.
  • Work under the direction of the Head of Commercial Operations, while collaborating with Field Service, In-House Repair, Technical Support, Field Sales, Contract Sales, Marketing, Finance, Master Data, Information Technology, Manufacturing, Logistics, Supply Chain, and other customer facing key stakeholders in administrative and operational matters to ensure effective achievement of the Sales Success business objectives.
  • Manage strategies that positively affect our Customer Perfect Order score.
  • Identify top drivers for customer calls and implement changes that reduce the customers need to call.
  • Evaluate overall Sales Success performance by gathering, analyzing and interpreting data and metrics.
  • Develop and publish customer focused metrics and controls on the performance of the Sales Success Teams. Ensure understanding and ownership of key measurements.
  • Develop and maintain Sales Success staff to support the Customer Care organization.
  • Influence leadership to drive process, strategy, and adherence to proper business protocols.

Zeiss SMT designs and makes high-precision optical systems for semiconductor manufacturing, including lithography optics, photomask solutions, and process-control components. Its products are used in lithography equipment to project circuit patterns onto silicon wafers, with responsibilities spanning advanced optics, mask technology, and monitoring tools that ensure precise, repeatable imaging.

Company Size

1,001-5,000

Company Stage

Growth Equity (Non-Venture Capital)

Total Funding

$1.1B

Headquarters

Oberkochen, Germany

Founded

2001

Simplify Jobs

Simplify's Take

What believers are saying

  • ASML's 24.9% stake secures long-term exclusive optics partnership.
  • Over 8,349 employees across nine global sites drive R&D innovation.
  • SFS's MultiSEM with 91 beams accelerates 2D process optimization.

What critics are saying

  • ASML pressures Zeiss for price cuts, eroding margins in 6-12 months.
  • Intel's 2025 High-NA EUV halt slashes Zeiss revenue by 20%.
  • SMEE's Q1 2026 7nm optics capture 30% of Zeiss Asia revenue.

What makes Zeiss unique

  • Exclusive supplier of optical systems for ASML's EUV lithography machines.
  • Three units: SMO for DUV/EUV/High-NA-EUV optics, SMS for photomasks, SFS for inspection.
  • Advances High-NA-EUV enabling three times more microchip structures.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Paid Vacation

Performance Bonus

Company News

PR Newswire
Apr 2nd, 2026
ZEISS unveils AI-powered patient platform and enhanced IOL tools at ASCRS

ZEISS has unveiled new digital, AI and surgical innovations for cataract and refractive workflows at the ASCRS conference. The medical technology company is expanding its US cataract portfolio with new irrigation/aspiration handpieces compatible with the DORC EVA NEXUS surgical system, alongside enhanced IOL calculation capabilities for the ZEISS IOLMaster 700. ZEISS also launched VisioGen commercially in the US, a human-verified AI patient engagement platform for ophthalmology practices. The platform integrates with clinic websites to capture patient demand around the clock, with AI-assisted responses reviewed by ZEISS-trained optometrists before delivery. The company showcased ZEISS Collaborative Care, a cloud-based application enabling secure data sharing between eye care professionals, and previewed ZEISS CLINIC 360, pending FDA clearance. ZEISS is celebrating 100 years of US operations this year.

PR Newswire
Mar 24th, 2026
ZEISS expands ophthalmic portfolio in Canada with new diagnostic lasers and workflow tools

ZEISS Medical Technology has expanded its ophthalmic workflow portfolio in Canada with new diagnostic, visualisation and therapeutic solutions. The company will showcase the innovations at upcoming Canadian ophthalmology conferences in Ottawa and Montréal. Key additions include ICGA for ZEISS CLARUS 700, offering simultaneous FA and ICG capture for clinical assessment, and ZEISS VISULAS green with selective laser trabeculoplasty for retinal photocoagulation. The company has introduced refraction devices ZEISS VISUREF 600 and ZEISS VISUCORE 500 to streamline diagnostic workflows. ZEISS also launched VISULAS yag, a new-generation therapeutic laser for anterior segment photodisruption within cataract workflows. The ZEISS FORUM subscription package, now available in Canada, offers integrated data management with unlimited device licences and lower upfront costs.

PR Newswire
Feb 23rd, 2026
ZEISS launches Collaborative Care app for eye care professionals with cloud and on-premises options

ZEISS Medical Technology has launched Collaborative Care, a browser-based application enabling eye care professionals to share data securely, refer patients and coordinate clinical care. Built on the ZEISS Health Data Platform, the solution addresses fragmented data sharing and inefficient referral processes in ophthalmic care. The application offers flexible deployment as either a standalone cloud solution or an integrated extension of ZEISS FORUM. Key features include secure exchange of images and reports, streamlined referral workflows with tracking capabilities, and tools for building professional networks between optometrists and ophthalmologists. ZEISS Collaborative Care was demonstrated at industry events in London and Orlando in February and March 2026. The company generated €2,228 million in revenue in fiscal year 2024/25 with 5,784 employees worldwide.

Handelsblatt
Feb 19th, 2026
Custom Surgical raises $4M to develop AI-powered ophthalmology platform

Custom Surgical, a German ophthalmology company, has raised €3.5 million to advance its platform. The funding will support development of AI-powered features including automated image optimisation and assisted triage processes that help determine case urgency and specialist assignment. The company is already developing its first AI-based triage and screening system. The technology aims to provide initial assessments that guide decisions on how urgently cases need attention and which medical professionals should handle them next.

Investors Hangout
Feb 18th, 2026
Mindpeak raises $15.3M Series A to scale AI cancer diagnostic tools

Mindpeak, an AI-driven pathology startup, raised $15.3 million in a Series A round led by ZEISS Ventures and InnoVentureFund in 2024. The funding will accelerate development and deployment of the company's AI diagnostic tools for cancer pathology. Founded in 2018, Mindpeak's algorithms have supported over 30,000 patient diagnoses across US and European healthcare markets. The technology uses automated histological analyses to help pathologists make faster, more precise clinical decisions. CEO Felix Faber stated the capital would expedite product rollouts and expand capabilities. The company has established strategic partnerships with major players including Roche. Mindpeak operates in the rapidly growing digital pathology market, driven by technological innovation and increasing demand for advanced diagnostic services in an ageing population.

INACTIVE